Based on the observed reduced expression of RBPMS in the cisplatin-resistant ovarian cancer cells (Figure 1E), we next aimed to determine whether RBPMS knockout reduced the sensitivity of ovarian cancer cells to cisplatin treatment. The gene discussed is RBPMS; the disease is ovarian carcinoma.